Duloxetine Capsule, Delayed Release
Product Images NDC 70518-1765

Description: DULoxetine is a medication available in delayed-release capsules. Each capsule contains 30 mg of the active ingredient. This product comes in a pack of 30 capsules and is available only with a prescription. The National Drug Code (NDC) for this medication is 70518-1765-00. The manufacturer of this product is Lupin Ltd, located in Goa, India. The medication should be kept out of the reach of children. The directions for use can be found in the package insert. It should be stored at temperatures between 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F) according to USP standards. The product has been repackaged by RemedyRepack Inc., located in Indiana, PA 15701. For any further information, contact 724.465.8762.*

The text provided appears to be a graphical representation showing the proportion of patients with relapse over time for a treatment compared to a placebo. The treatment being evaluated is likely called "DULOXETINE." The graph shows time from randomization to relapse in days, and the numbers provided seem to represent different time points or intervals. However, without further context or a clear image of the graph, it is difficult to provide a more detailed description.*

Percentage of Patients Improved This text appears to be a report or analysis of the percentage of patients who experienced improvement in a certain condition or symptom. The specific treatment being evaluated is duloxetine, with different dosages of 60 mg and 20 mg administered either once daily (QD) or twice daily (BID). The text also mentions a placebo group. The percentage of improvement is not mentioned in the given text, and further information is needed.*

Percentage of Patients Improved: This text appears to be a table or a section of a larger document. It mentions the "Percentage of Patients Improved" and "Percent Improvement in Pain from Baseline." It also lists different treatments or medications: "Duloxsine 60 mg BID," "Duloxetine 60 mg QD," and "Placebo." However, the specific information or data related to these percentages is not provided in the given text.*

Percentage of Patients Improved: This text provides information on the percentage of patients who experienced improvement in their pain levels. It mentions different doses of Duloxetine medication, including 120 mg twice daily, 60 mg once daily, and a placebo. The specific percentage of improvement is not mentioned and instead, there are symbols and numbers indicating different levels of improvement. Unfortunately, the text does not provide enough readable information to determine the exact percentage of improvement.*

Percentage of Patients Improved: This text provides information about the percentage of patients who experienced improvement in their condition. However, without further details or context, it is not possible to determine the specific condition or treatment being referred to.*